propionylcarnitine has been researched along with Diabetes Mellitus, Type 2 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caliumi, C; Carloni, E; D'andrea, P; Izzo, A; Liguori, M; Palermo, G; Paolucci, AM; Pompili, S; Riccioni, C; Sarcinella, R | 1 |
| Alvarez de Sotomayor, M; Herrera, MD; Justo, ML; Mingorance, C; Rodríguez-Rodríguez, R | 1 |
| Acerra, G; del Guercio, R; Fasano, C; Federico, P; Gioia, F; Madrid, E; Mattera, E; Ragozzino, G; Salomone, P | 1 |
| Lango, R; Lysiak-Szydłowska, W; Rogowski, J; Siebert, J; Smoleński, RT; Słomińska, EM; Wujtewicz, M; Yacoub, MH | 1 |
| Gabriella, C; Gea, OC; Giuseppe, M; Giuseppe, P; Luigi, DP; Margherita, F; Massimiliano, A; Roberto, F; Santo, SS; Sergio, N | 1 |
| Buchetti, B; Fallarino, M; Gandini, L; Gatti, A; Jannini, EA; Lenti, L; Lenzi, A; Mandosi, E; Morano, S; Sensi, M; Tiberti, C | 1 |
| Salonia, A | 1 |
| Pickard, R | 1 |
| Izzo, A; Koverech, A; Liguori, M; Messano, M; Palermo, G; Riccioni, C; Sarcinella, R; Virmani, A | 1 |
1 review(s) available for propionylcarnitine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.
Topics: Acetylcarnitine; Animals; Cardiovascular Agents; Cardiovascular Diseases; Carnitine; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Insulin Resistance; Treatment Outcome | 2011 |
5 trial(s) available for propionylcarnitine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of propionyl-carnitine in patients with type 2 diabetes and peripheral vascular disease: results of a pilot trial.
Topics: Blood Glucose; Carnitine; Diabetes Mellitus, Type 2; Female; Humans; Injections, Intravenous; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Treatment Outcome; Vasodilator Agents | 2004 |
Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients.
Topics: Aged; Blood Pressure; Cardiopulmonary Bypass; Cardiotonic Agents; Carnitine; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoxanthine; Lactic Acid; Male; Middle Aged; Muscle, Skeletal; Myocardium | 2005 |
Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD.
Topics: Aged; Aldehydes; Ankle; Blood Glucose; Blood Pressure; Brachial Artery; Carnitine; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Glycated Hemoglobin; Humans; Malondialdehyde; Middle Aged; Oxidation-Reduction; Pain Measurement; Placebos | 2006 |
Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
Topics: Aged; Antioxidants; Biomarkers; Carnitine; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Erectile Dysfunction; Glycated Hemoglobin; Humans; Male; Middle Aged; Monocytes; Phosphodiesterase Inhibitors; Piperazines; Purines; Reactive Oxygen Species; Sildenafil Citrate; Sulfones | 2007 |
Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
Topics: Aged; Arterial Occlusive Diseases; Cardiovascular Agents; Carnitine; Combined Modality Therapy; Diabetes Mellitus, Type 2; Female; Humans; Infusions, Intravenous; Intermittent Claudication; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Quality of Life; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome; Walking | 2008 |
3 other study(ies) available for propionylcarnitine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Rehabilitative treatment in peripheral artery disease: protocol application and follow-up.
Topics: Aged; Cardiotonic Agents; Carnitine; Clinical Protocols; Combined Modality Therapy; Diabetes Mellitus, Type 2; Exercise Therapy; Extremities; Female; Follow-Up Studies; Humans; Ischemia; Male; Middle Aged; Peripheral Arterial Disease; Regional Blood Flow; Walking | 2010 |
Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
Topics: Antioxidants; Carnitine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Monocytes; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2007 |
Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
Topics: Antioxidants; Carnitine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2007 |